#aaeth ,,congress  #b;d ,session  ,h4   
,r4 #affj  ,,an ,,act  ,to direct the   
,administrator of the ,united ,states   
,agency for ,international ,development 
to submit to ,congress a report on the  
development and use of global health    
innovations in the programs1 projects1  
and activities of the ,agency4  #a4     
,short title ,this ,act may be cited as 
the ,global ,health ,innovation ,act of 
#bjag4  #b4 ,annual report  7a7 ,in     
general ,not later than #ahj days after 
the date of the enactment of this ,act1 
and annually thereafter for a period of 
#d years1 the ,administrator of the     
,united ,states ,agency for             
,international ,development shall submit
 to ,congress a report on the           
development and use of global health    
innovations in the programs1 projects1  
and activities of the ,agency4  7b7     
,matters ,to ,be ,included ,the report  
required by subsection 7a7 shall include
 the following3 7#a7 ,a description of--
  7,a7 the extent to which global health

 innovations described in subsection 7a7
 include drugs1 diagnostics1 devices1   
vaccines1 electronic and mobile health  
technologies1 and related behavior      
change and service delivery innovations2
  7,b7 how innovation has advanced the  
,agency's commitments to achieving an   
,,hiv_/,,aids-free generation1 ending   
preventable child and maternal deaths1  
and protecting communities from         
infectious diseases1 as well as         
furthered by the ,global ,health        
,strategic ,framework2  7,c7 how goals  
are set for health product development  
in relation to the ,agency's            
health-related goals and how progress   
and impact are measured towards those   
goals2  7,d7 how the ,agency's          
investments in innovation relate to its 
stated goals2 and  7,e7 progress made   
towards health product development      
goals4  7#b7 ,how the ,agency1 both     
independently and with partners1 donors1
 and public-private partnerships1 is--  
7,a7 leveraging ,united ,states         

investments to achieve greater impact in
 health innovation2  7,b7 engaging in   
activities to develop1 advance1 and     
introduce affordable1 available1 and    
appropriate global health products2 and 
7,c7 scaling up appropriate health      
innovations in the development pipeline4
  7#c7 ,a description of collaboration  
and coordination with other ,federal    
departments and agencies1 including the 
,centers for ,disease ,control and      
,prevention1 in support of global health
 product development1 including a       
description of how the ,agency is       
working to ensure critical gaps in      
product development for global health   
are being filled4  7#d7 ,a description  
of how the ,agency is coordinating and  
aligning global health innovation       
activities between the ,global          
,development ,lab1 the ,center for      
,accelerating ,innovation and ,impact1  
and the ,bureau for ,global ,health4    
,passed the ,house of ,representatives  
,january #ah1 #bjah4;,clerk4